Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience-Reference-Cited by-同舟云学术

Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience

Published:2020-10 Issue: Volume:80 Page:74-78
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Yu Nathan Y.,Sio Terence T.,Lyons Mark K.,Vora Sujay A.,Turkmani Ali,Brown Paul D.,Park Sean S.,Leenstra James L.,Bendok Bernard R.,Schild Steven E.,Ashman Jonathan B.

Publisher

Elsevier BV

Subject

Physiology (medical),Clinical Neurology,Neurology,General Medicine,Surgery

Reference20 articles.

1. Tumors of the spine;Ciftdemir;World J Orthop,2016

2. Vertebral hemangiomas: diagnosis, management, natural history and clinicopathological correlates in 86 patients;Pastushyn;Surg Neurol,1998

3. Vertebral hemangiomas presenting with neurologic symptoms;Nguyen;Surg Neurol,1987

4. Osseous hemangioma of the seventh cervical vertebra with osteoid formation mimicking metastasis: a case report;Lakemeier;J Med Case Rep,2009

5. Lumbar vertebral haemangioma causing pathological fracture, epidural haemorrhage, and cord compression: a case report and review of literature;Vinay;J Spinal Cord Med,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Historical Survey of Key Epidemiological Studies of Ionizing Radiation Exposure;Radiation Research;2024-07-18

2. Effective and Successful Control of Symptomatic Vertebral Hemangiomas With Epidural Extension Using Stereotactic Spine Radiosurgery;Neurosurgery;2024-04-19

3. A Strategic Approach to Addressing Aggressive Vertebral Hemangiomas With Hypofractionated Stereotactic Body Radiotherapy;Cureus;2024-03-25

4. Surgical Options for Aggressive Vertebral Hemangiomas：A case series, literature review and treatment recommendations;Journal of Bone Oncology;2023-12

5. Benign Tumors/Premalignant Conditions;Radiation Therapy of Benign Diseases;2023